Atlas Trials

Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preeclampsia

Clinical trial NCT07572656 · COMPLETED

Trial details

NCT number
NCT07572656
Sponsor
Muhammad Aamir Latif
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Preeclampsia
Start date
2024-05-01
Primary completion
2024-10-31
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.